Rybelsus®

Semaglutide

Rybelsus® tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus® can be prescribed when other diabetes medicines have been tried without success and should be used together with diet and exercise. Rybelsus® tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating.
more
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
Rp 244507.70
Rp 22005692.89Rp 244507.70
Rp 2932570.95
60 tablet
Free AirMail shipping Hot
Rp 260804.29
Rp 15648257.26Rp 260804.29
Rp 977251.96
30 tablet
Free AirMail shipping Hot
Rp 277091.82
Rp 8312754.61Rp 277091.82
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
Rp 293411.05
Rp 26406994.48Rp 293411.05
Rp 1465470.42
60 tablet
Free AirMail shipping Hot
Rp 301557.08
Rp 18093424.81Rp 301557.08
Rp 488218.45
30 tablet
Free AirMail shipping Hot
Rp 309694.05
Rp 9290821.63Rp 309694.05
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
Rp 350464.96
Rp 31541846.34Rp 350464.96
Rp 1465470.42
60 tablet
Free AirMail shipping Hot
Rp 358610.99
Rp 21516659.38Rp 358610.99
Rp 488218.45
30 tablet
Free AirMail shipping Hot
Rp 366747.96
Rp 11002438.92Rp 366747.96
Rybelsus

Brand(s)

Manufacturer

  • Novo Nordisc India Pvt. Ltd

Disease(s)

  • Type 2 Diabetes Mellitus / High Blood Sugar

Rybelsus® tablets

What is Rybelsus?

Rybelsus tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus can be prescribed when other diabetes medicines have been tried without success, and should be used together with diet and exercise.

Rybelsus tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating. Rybelsus is from the class of medicines called GLP-1 receptor agonists.
Rybelsus is not for treating type 1 diabetes.
Rybelsus was first approved by the FDA on September 20, 2019.

Warnings

You should not use Rybelsus if you have multiple endocrine neoplasia type 2 (tumors in your glands), a personal or family history of medullary thyroid cancer, insulin-dependent diabetes, or diabetic ketoacidosis.
Call your doctor at once if you have signs of a thyroid tumor, such as swelling or a lump in your neck, trouble swallowing, a hoarse voice, or shortness of breath.